Bezlotoxumab Versus FMT for Multiple Recurrent CDI

NCT05077085 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Withdrawn

Conditions

Clostridium Infections
Clostridioides Difficile
Enterocolitis, Pseudomembranous

Interventions

DRUG: Bezlotoxumab
PROCEDURE: Fecal Microbiota Transplantation (FMT)
DRUG: Vancomycin oral

Sponsor

Leiden University Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]